Quick Financials Update
On August 29, 2013, Avita Medical Ltd (AVMXY.OB) reported financial results for the six months and full year ended June 30, 2013. Total revenues for the six months ended June 30, 2013 were $2.18 million, up 13% over the same period in 2012. Revenues were driven by $1.46 million in product sales, consisting of sales of the ReCell® Spray-On Skin product in Europe and sales of the Breath-A-Tech® spacer and Funhaler® children's inhaler in Australia, and $0.72 million in grants relating to the U.S. Department of Defense and other income. For the full year 2013, revenues totaled $4.05 million, consisting of $2.82 million in product sales from ReCell, Breath-A-Tech, and Funhaler, and $1.24 million in grants and other income.
Gross margin on product sales was roughly 76% in 2013, but has been steadily rising over the past year - from 71.6% in fiscal 2012, to 73.6% in the first half of 2013, to 78.2% in the second half of 2013. Operating expenses totaled $12.27 million, consisting of $2.60 million in R&D, $8.92 million in SG&A, and $0.07 million in other expenses. The company reported a net loss for the six months ending June 30, 2013 of $4.21 million, or $0.24 per share U.S. ADR. For the full year fiscal 2013, loss totaled $7.96 million, or $0.52 per ADR.
Top 10 Insurance Companies For 2015: BYD Co Ltd (BYDDF)
BYD COMPANY LIMITED is principally engaged in the research, development, manufacture and distribution of automobiles, secondary rechargeable batteries and mobile phone components. The Company operates its businesses primarily through secondary rechargeable battery business, which provides lithium-ion batteries and nickel batteries, which are applied in mobile phones, digital cameras, electric tools, electric toys and other portable electronic devices; mobile phone components and assembly businesses, which offers casings, keypads, liquid crystal display (LCD) modules, cameras, flexible circuit boards, chargers, and mobile phone design and assembly services, as well as automobile business, which provides automobiles, including G6, S6 and other series. Advisors' Opinion:- [By Chris Isidore]
Shares of Tesla (TSLA) shot up as high as $196, before easing off those highs later in the day. That topped the previous record set Sept. 30 Shares of Chinese electric carmaker BYD (BYDDF), in which Warren Buffett's Berkshire Hathaway (BRKA, Fortune 500) has taken a stake, were also higher in trading in China and the United States.
Top 10 Industrial Disributor Companies To Watch In Right Now: Century Aluminum Company(CENX)
Century Aluminum Company, through its subsidiaries, produces primary aluminum in the United States, China, and Iceland. The company offers high purity primary aluminum, molten aluminum, standard-grade ingots, extrusion billets, and other value-added primary aluminum products. It also holds a 40% joint venture interest in a carbon anode and cathode facility located in the Guangxi Zhuang Autonomous Region of south China. The company was founded in 1981 and is headquartered in Monterey, California.
Advisors' Opinion:- [By Jake L'Ecuyer]
Leading and Lagging Sectors
Basic materials shares jumped about 1.72 percent in Monday's trading. Leading the sector was strength from Century Aluminum Co (NASDAQ: CENX) and Horsehead Holding (NASDAQ: ZINC). In trading on Monday, utilities shares dropped by 0.13 percent. - [By Rich Smith]
Even as it contemplates shutting down its largest aluminum smelter in the United States, Century Aluminum (NASDAQ: CENX ) says it's planning to buy another smelter entirely. On Monday, Century announced that it's signed a definitive agreement to buy Rio Tinto's (NYSE: RIO ) Sebree aluminum smelter in Henderson County, Ky.
Top 10 Industrial Disributor Companies To Watch In Right Now: CVS Corporation(CVS)
CVS Caremark Corporation operates as a pharmacy services company in the United States. The company?s Pharmacy Services segment provides a range of pharmacy benefit management services, including mail order pharmacy services, specialty pharmacy services, plan design and administration, formulary management, and claims processing; and drug benefits to eligible beneficiaries under the Federal Government?s Medicare Part D program. This segment primarily serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals. As of December 31, 2010, it operated 44 retail specialty pharmacy stores, 18 specialty mail order pharmacies, and 4 mail service pharmacies located in 25 states, Puerto Rico, and the District of Columbia. This segment operates business under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, CarePlus, RxAmerica, Accordant, and TheraCom names. The company?s Retail Pharmacy segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, seasonal merchandise, greeting cards, and convenience foods through its pharmacy retail stores and online, as well as offers film and photo finishing, and health care services. This segment operated 7,182 retail drugstores located in 41 states, Puerto Rico, and the District of Columbia; and 560 retail health care clinics in 26 states and the District of Columbia under the MinuteClinic name. It has a strategic alliance with Alere, L.L.C. for the management of disease management program offerings that cover chronic diseases, such as asthma, diabetes, congestive heart failure, and coronary artery disease. CVS Caremark Corporation was founded in 1892 and is based in Woonsocket, Rhode Island.
Advisors' Opinion:- [By Matt Brownell]
Alamy Following an onslaught of media coverage and social media mockery, CVS has agreed to stop giving comically long receipts to its ExtraCare Rewards members. In a Facebook post Friday night, CVS (CVS) chief marketing officer Rob Price acknowledged the complaints about its receipts -- which in some cases measure more than 3 feet long for a single item -- and said it would take steps to shorten them. "You asked for ALL the savings and LESS paper," he wrote. "So, we've found a way to reduce the size of the ExtraCare portion of your receipts by 25% while still providing you all the coupons and rewards." He went on to say that the shorter receipts will be rolling out in the next few weeks, and that the "Send to Card" program, which allows you to send select coupon offers directly to your ExtraCare card, will be expanded next year to include all coupons and offers. That means that ExtraCare members can get all the offers, but with a standard-sized receipt. We stumbled across the issue last week, when an AOL employee bought a single item at a local CVS and wound up with a 38-inch receipt. As we would discover, plenty of shoppers had begun grumbling on social media about similarly long receipts, with some musing about alternative uses for the paper. Other media outlets, including FastCompany and the Huffington Post, likewise picked up on the spreading meme. In its post Friday, CVS showed some sense of humor, acknowledging the "very creative uses" people had come up with for their receipts. It's worth noting that the receipts are still going to be pretty long. It's only a 25% reduction, and only in the coupon portion of the receipt; by our math, that's a reduction of between 6 and 10 inches, so you're still looking at receipts that are upwards of 2 feet in length. That's not quite long enough to wear as a beauty pageant sash, and will prompt a bit less mockery on Twitter, but it still seems like quite a waste of paper. So if that's a concern for you, by all mea
- [By Keith Speights]
Express Scripts isn't alone in experiencing improved generic utilization. CVS Caremark (NYSE: CVS ) saw its overall rate increase from 76.5% in its first quarter of 2012 to 80.5% in the same quarter this year. UnitedHealth didn't report detailed numbers for OptumRx last quarter, but noted that it was seeing improvements in its generic mix that helped drive earnings higher. Catamaran (NASDAQ: CTRX ) also experienced a solid 3% year-over-year jump during the first quarter to 83%.
Top 10 Industrial Disributor Companies To Watch In Right Now: Unilife Corporation(UNIS)
Unilife Corporation, together with its subsidiaries, engages in the development and manufacture of advanced drug delivery systems in the United States and internationally. The company offers Unifill Syringe, a prefilled syringe designed for safe, simple, and convenient use by either healthcare workers or patients who self-administer prescription medication; and Unitract 1mL Syringes that are primarily designed for the subcutaneous injection of drugs within healthcare facilities and by patients who self-administer prescription medication, such as insulin. Its pipeline products include Unifill Select syringes, which facilitate the use of injectable drugs and vaccines between 0.2 and 1.5mL in volume that are supplied in either a liquid stable form or lyophilized for reconstitution; Unifill EZMix for the unmet needs of pharmaceutical companies seeking a delivery system for the reconstitution and administration of lyophilized drugs and vaccines; Unifill Auto-Injectors for the a ccurate, intuitive, and convenient administration of injectable drugs by patients outside of healthcare facilities; and Auto-Infusors, a range of single-use and disposable subcutaneous infusion systems for the patient self-injection of drugs between 3mL and 10mL in volume; and a novel device for the administration of a drug to a target organ. Unilife?s target customers include pharmaceutical and biotechnology companies seeking to optimize drug lifecycles and generate differentiation for their brand in competitive therapeutic markets through the use of innovative devices that can improve patient care, protect healthcare workers, and prevent disease; and suppliers of medical equipment to healthcare facilities and distributors to patients who self-administer prescription medication. The company is headquartered in York, Pennsylvania.
Advisors' Opinion:- [By Paul Ausick]
Stocks on the Move: Voxeljet AG (NYSE: VJET) is down 32.5% at $39.15 on both a momentum move and a scathing report from a short-seller. Unilife Corp. (NASDAQ: UNIS) is up 43.9% at $4.03 after signing a long-term contract for its syringes.
- [By Laura Brodbeck]
Next week investors will be waiting for several key earnings reports includingSotheby�� (NYSE: BID), Unilife Corporation (NASDAQ: UNIS), DISH Network Corporation (NASDAQ: DISH), Macy�� Inc. (NYSE: M), Wal-Mart Stores, Inc. (NYSE: WMT)
Top 10 Industrial Disributor Companies To Watch In Right Now: J&J Snack Foods Corp (JJSF)
J & J Snack Foods Corp. (J & J), incorporated in 1971, manufactures nutritional snack foods and distributes frozen beverages, which it markets nationally to the food service and retail supermarket industries. The Company�� principal snack food products are soft pretzels marketed under the brand name SUPERPRETZEL and frozen juice treats and desserts marketed under the LUIGI��, WHOLE FRUIT, ICEE and MINUTE MAID brand names. In June 2012, the Company acquired the assets of Kim & Scott�� Gourmet Pretzels, Inc., a manufacturer and seller of a brand soft pretzel. In October 2013, J & J Snack Foods Corp. acquired the assets of New York Pretzel.
J & J is a manufacturer of soft pretzels in the United States, Mexico and Canada. Other snack food products include churros (an Hispanic pastry), funnel cake, dough enrobed handheld products and bakery products. The Company�� principal frozen beverage products are the ICEE brand frozen carbonated beverage and the SLUSH PUPPIE brand frozen uncarbonated beverage. The Company�� Food Service and Frozen Beverages sales are made to food service customers, including snack bar and food stand locations in chain, department, discount, warehouse club and convenience stores; malls and shopping centers; fast food outlets; stadiums and sports arenas; leisure and theme parks; movie theatres; independent retailers, and schools, colleges and other institutions. The Company�� retail supermarket customers are supermarket chains. The Company operates in three business segments: Food Service, Retail Supermarkets and Frozen Beverages.
The products sold by the food service segment are soft pretzels, frozen juice treats and desserts, churros, dough enrobed handheld products and baked goods. Its customers in the food service segment include snack bars and food stands in chain, department and discount stores; malls and shopping centers; casual dining restaurants; fast food outlets; stadiums and sports arenas; leisure and theme parks; convenience stores; m! ovie theatres; warehouse club stores; schools, colleges, and other institutions. The products sold to the retail supermarket channel are soft pretzel products, including SUPERPRETZEL, frozen juice treats and desserts, including LUIGI�� Real Italian Ice, MINUTE MAID Juice Bars and Soft Frozen Lemonade, WHOLE FRUIT frozen fruit bars and sorbet, ICEE Squeeze-Up Tubes and dough enrobed handheld products, including PATIO burritos. The Company sells frozen beverages to the food service industry primarily under the names ICEE, SLUSH PUPPIE, PARROT ICE and ARCTIC BLAST in the United States, Mexico and Canada. It also provides repair and maintenance service to customers for customers��owned equipment.
Soft Pretzels
The Company�� soft pretzels are sold under many brand names, which are SUPERPRETZEL, PRETZEL FILLERS, PRETZELFILS, GOURMET TWISTS, MR. TWISTER, SOFT PRETZEL BITES, SOFTSTIX, SOFT PRETZEL BUNS, TEXAS TWIST, CINNAPRETZEL and SERIOUSLY TWISTED!; and under private labels. Soft pretzels are sold in the Food Service and Retail Supermarket segments. During fiscal year ended September 29, 2012 (fiscal 2012), soft pretzel sales amounted to 18% of the Company�� revenue.
Soft pretzels, ranging in size from one to ten ounces in weight, are shaped and formed by the Company�� twister machines. These soft pretzel tying machines are for twisting dough into the traditional pretzel shape. In addition, it makes soft pretzels, which are extruded or shaped by hand. The Company�� marketing program in the Food Service segment includes supplying ovens, mobile merchandisers, display cases, warmers and similar merchandising equipment to the retailer to prepare and promote the sale of soft pretzels.
Frozen Juice Treats and Desserts
The Company�� frozen juice treats and desserts are marketed primarily under the LUIGI��, WHOLE FRUIT, ICEE and MINUTE MAID brand names. Frozen juice treats and desserts are sold in the Food Service and Retail Supermarke! ts segmen! ts. During fiscal 2012, frozen juice treats and dessert sales were 13% of the Company�� revenue.
The Company�� school food service MINUTE MAID and WHOLE FRUIT frozen juice bars and cups are manufactured from an apple or pineapple juice concentrate to which water, sweeteners, coloring (in some cases) and flavorings are added. The juice bars are produced in various flavors and are packaged in a sealed push-up paper container referred to as the Milliken M-pak. The balance of the Company�� frozen juice treats and desserts products are manufactured from water, sweeteners and fruit juice concentrates in various flavors and packaging, including cups, tubes, sticks, M-paks, pints and tubs.
Churros
The Company�� churros are sold under the TIO PEPE�� and CALIFORNIA CHURROS brand names. Churros are sold to the Food Service and Retail Supermarkets segments. During fiscal 2012, Churro sales were 6% of the Company�� sales. Churros are Hispanic pastries in stick form, which the Company produces in several sizes. The churros are deep fried, frozen and packaged. At food service point-of-sale they are reheated and topped with a cinnamon sugar mixture. The Company also sells fruit and creme-filled churros. The Company supplies churro merchandising equipment.
Handheld Products
The Company's dough enrobed handheld products are marketed under the PATIO, HAND FULLS, HOLLY RIDGE BAKERY, VILLA TALIANO, TOP PICKS brand names and under private labels. Handheld products are sold to the Food Service and Retail Supermarket segments. During fiscal 2012, handheld product sales amounted to 6% of the Company's sales.
Bakery Products
The Company�� bakery products are marketed under the MRS. GOODCOOKIE, READI-BAKE, COUNTRY HOME, MARY B��, DADDY RAY�� and JANA�� brand names, and under private labels. Bakery products include biscuits, fig and fruit bars, cookies, breads, rolls, crumb, muffins and donuts. Bakery products are sold ! to the Fo! od Service segment. During fiscal 2012, bakery products sales amounted to 32% of the Company�� sales.
Frozen Beverages
The Company markets frozen beverages primarily under the names ICEE, SLUSH PUPPIE, PARROT ICE and ARCTIC BLAST in the United States, Mexico and Canada. During fiscal 2012, frozen beverages are sold in the Frozen Beverages segment. During fiscal 2012, frozen beverage sales amounted to 16% of revenue in fiscal 2012.
Under the Company�� principal marketing program for frozen carbonated beverages, it installs frozen beverage dispensers for its ICEE and ARCTIC BLAST brands at customer locations and thereafter services the machines, arranges to supply customers with ingredients required for production of the frozen beverages, and supports customer retail sales efforts with in-store promotions and point-of-sale materials. During fiscal 2012, the Company also provided repair and maintenance service to customers for customers��owned equipment and sells equipment in its Frozen Beverages segment, revenue from which amounted to 7% of sales. The Company sells frozen un-carbonated beverages under the SLUSH PUPPIE and PARROT ICE brands through a distributor network and through its own distribution network.
Each new frozen carbonated customer location requires a frozen beverage dispenser supplied by the Company or by the customer. Company-supplied frozen carbonated dispensers are purchased from outside vendors, built new or rebuilt by the Company. The Company provides managed service and/or products to approximately 87,000 Company-owned and customer-owned dispensers.
Other Products
Other products sold by the Company include soft drinks, funnel cakes sold under the FUNNEL CAKE FACTORY brand name and smaller amounts of various other food products. These products are sold in the Food Service and Frozen Beverages segments.
Advisors' Opinion:- [By Geoff Gannon] out the performance numbers on those three stocks over the last 10-13 years (I bought them at different times). You��l notice that if I just never sold those stocks I wouldn�� need to do anything else. Those three stocks would��e made a fine portfolio for the next decade or so.
Well, I did sell those stocks. And I did a lot else. And some of it worked very well and some of it worked very badly. But, almost without fail, the net result was never better than what would have happened if I�� kept those three stocks.
That�� not an accident. It took me a very, very long time to buy stocks when I was a kid. I bought six stocks in my first five years as an investor. That�� not quite a 20 punches approach ��but it�� pretty close.
Why did I only buy one stock a year?
Because I didn�� know anything about stocks. And I didn�� think I knew anything about stocks.
My investment style was formed from a combination of extreme ignorance and extreme confidence. I was totally ignorant about stocks. And I was totally confident that I could learn all I needed to know about the stocks I needed to know about.
That combination led to focusing on a few very specific stocks. Stocks I was comfortable with.
When I was 14, there were only two places my money went. Into my brokerage account. Or into video games. So it�� not a surprise I bought Activision. At the time the video game industry had a much clearer future than it does today. And there was no better CEO of a video game company than Bobby Kotick. The balance sheet was pristine. When you backed out cash, the stock was cheap relative to sales. I looked at everything I could about video game companies and I decided sales were pretty profitable and pretty cash generative in this industry. All you needed was sensible capital allocation. All you needed was management that was going to run the place like a business. And I thought you had that.
I worked as a cashier at Vi
- [By Suravi Thacker]
Food industry is one of the safest options to invest in since food can never be out of vogue. Moreover, even snack making industry is quite a lucrative one with some of the prominent players being Kellogg (K), Mondelez International (MDLZ) and J&J Snack Foods (JJSF). However, it is important to understand which among these will be the best pick for any investor.
- [By John Kell and Lauren Pollock var popups = dojo.query(".socialByline .popC"); ]
Hologic Inc.(HOLX) named Eric Compton as its chief operating officer, a newly created position, amid a handful of leadership changes at the medical-equipment maker. Mr. Compton most recently worked as the world-wide president of Johnson & Johnson’s Ortho-Clinical Diagnostics. J&J(JJSF) in January agreed to sell the�blood-testing business for $4.15 billion to Carlyle Group L.P(CG).
Top 10 Industrial Disributor Companies To Watch In Right Now: Canadian Mining Co Inc (CNG)
Canadian Mining Company Inc. (Canadian Mining) is engaged in the evaluation, acquisition, exploration, development and operation of mineral properties in British Columbia, Arizona, the United States and Sonora, Mexico. The Company�� projects include Bullard Pass Property, and Raquel 3 Concession. During the fiscal year ended June 30, 2012 (fiscal 2012), the Company had interests in two mineral properties located in British Columbia: Sun Group and Bromley Creek. In British Columbia, the Company�� principal property interest is its Bromley Creek zeolite project, which consists of a total of one mineral lease and six mineral claims. The Company has contiguous claim, number 305975, located in the Similkameen Mining District of British Columbia. The total claim area includes 843.468 hectares. During fiscal 2012, Canadian Mining completed phase one of a drilling program in Bullard Pass Gold Property. Advisors' Opinion:- [By Tyler Laundon]
It has a vision of building America's Natural Gas Highway. The project consists of a compressed natural gas (CNG) and liquefied natural gas (LNG) fuel-station network connecting 48 states.
Top 10 Industrial Disributor Companies To Watch In Right Now: Perrigo Company PLC (PRGO)
Perrigo Company plc, incorporated on March 23, 1988, is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri. The Company�� businesses include Consumer Healthcare, Nutritionals, Rx Pharmaceuticals, API, Life Sciences and Other Businesses. The Company offers Healthcare Products across a range of product categories primarily in the United States, the United Kingdom, Mexico, Israel and Australia, and distributes into dozens of other markets worldwide, including Canada, China and Latin America. In February 2014, the Company announced that it has acquired a basket of value-brand OTC products sold in Australia and New Zealand from Aspen Global Inc.
The Company operates through several wholly owned subsidiaries. In the United States, its operations are conducted primarily through L. Perrigo Company, Perrigo Company of South Carolina, Inc., Perrigo New York, Inc., PBM Products, LLC, PBM Nutritionals, LLC, Paddock Laboratories, LLC, Perrigo Diabetes Care, LLC (formerly CanAm Care, LLC), Sergeant's Pet Care Products, Inc. and Fidopharm, Inc. Outside the United States, its operations are conducted primarily through Perrigo Israel Pharmaceuticals Ltd., Chemagis Ltd., Quimica y Farmacia S.A. de C.V., Laboratorios Diba, S.A., Wrafton Laboratories Limited, Galpharm Healthcare Ltd., Orion Laboratories Pty Ltd and Rosemont Pharmaceuticals Ltd.
Consumer Healthcare
Perrigo Consumer Healthcare (CHC) operation includes the Company's United States, United Kingdom and Mexico manufacturing operations supporting the sale of OTC pharmaceutical products. Perrigo CHC supplies more than 15 categories and 500 formulas and offers analgesics, cough and cold remedies, and gastrointestinal and feminine hygiene products, as w! ell as vitamins, dietary supplements and nutritional drinks. Perrigo offers a range of products, such advertised brand products as Tylenol, Advil or One-A-Day. Tylenol has acetaminophen as an active ingredient and is available in stores' analgesic (pain reliever) aisle. Store-brand acetaminophen is located next to the national brand, offering the same active ingredient (acetaminophen) and the same pain relief.
Perrigo Nutritionals
Perrigo is a manufacturer of nutrition products for the store brand market. Nutrition products include infant formula, pediatric nutritionals and vitamins, minerals, and supplements. Acquired by Perrigo, Perrigo Nutritionals, formerly PBM Products, LLC, had introduced private-label, or store-brand infant formulas to the United States. Perrigo Nutritionals is the supplier of store-brand infant formulas and nutrition products. With distribution to major retailers, Perrigo Nutritional products can be found in more than 40,000 retail locations around the world. Its pediatric nutritionals business extends its offerings to children well beyond infancy. Its baby cereals, toddler foods, and pediatric nutritional drinks are available as store brands at various retail locations throughout the United States and the international community. Perrigo manufactures a range of vitamins, minerals, and supplements, in every major segment of the business. Marketed under the store brand labels of the retailers in the food, drug, mass-merchandise and wholesale club channels, it manufactures over 395 formulas of dietary supplements. Its brands include Centrum, One-A-Day, Flintstones, and Osteo-Bi-Flex.
Rx Pharmaceuticals
The Company�� Rx Pharmaceuticals business is focused on the development, manufacture and sale of generic prescription drug products, primarily for the United States market. Manufacturing operations are based in the United States and Israel. Perrigo's portfolio focuses on complex, high-barrier ophthalmological, topical foam and or! al liquid! formulations. Its products include Acetylcysteine Injection 200 mg/mL (6g/30mL), Acetylcysteine Injection 6 g/30 mL (200 mg/1 mL), NOVAPLUS, ACTIDOSE with SORBITOL, ACTIDOSE-AQUA, ASPIRIN SUPPOSITORIES USP, Bacitracin Ophthalmic Ointment USP, Belladonna and Opium Suppositories C-II, BENZOIN COMPOUND TINCTURE USP, Benzoyl Peroxide 10% Acne Medication Wash, CLOBETASOL PROPIONATE LOTION 0.05% and Docusate Sodium.
Active Pharmaceutical Ingredients
Primarily through the Company�� Israel-based business, Perrigo develops, manufactures and markets the complex chemicals and active pharmaceutical ingredients used worldwide by the generic drug industry. Certain of these ingredients are also used in Perrigo's own pharmaceutical products. It manufactures API at facilities in Israel, India and China. Perrigo API specializes in tailor-made research and process development of APIs and Finished Dosage Forms (FDFs).
Life Sciences
Through the Company�� Israel-based business, Perrigo markets and manufactures branded prescription drugs and medical diagnostic products through exclusive agreements with pharmaceutical companies. Its Pharmaceutical and Medical Diagnostic Products businesses also market and manufacture branded prescription drugs under licenses. Other pharmaceutical and medical diagnostics products are imported to Israel through exclusive agreements. Products in life sciences segment include TYSABRI and ELND005. TYSABRI (natalizumab) is indicated for treatment of: Multiple Sclerosis: as monotherapy for the treatment of patients with relapsing forms of multiple sclerosis to delay the accumulation of physical disability and reduce the frequency of clinical exacerbations. TYSABRI is recommended for patients who have had an inadequate response to, or are unable to tolerate, an alternate MS therapy; Crohn�� Disease (CD): Inducing and maintaining clinical response and remission in adult patients with moderately to severely active Crohn�� disease with e! vidence o! f inflammation who have had an inadequate response to, or are unable to tolerate, conventional CD therapies and inhibitors of tumor necrosis factor-伪.
Other
Perrigo's Pharmaceutical and Medical Diagnostic Products business markets and manufactures branded prescription drugs under licenses. Other pharmaceutical and medical diagnostic products are imported to Israel through exclusive agreements with pharmaceutical and diagnostics companies. This business is divided into two departments: Pharma-Israel and Tayco Diagnostics. Pharma-Israel operates in the Israeli market as a partner in the marketing, sales and distribution of Rx (dermatology, gastroenterology, blood products, CNS, urology and other fields), OTC, generics, branded generics, dermo-cosmetics and dietary supplements. Tayco, the diagnostics division of Perrigo-Israel Pharmaceuticals Ltd., specializes in marketing and sales of medical laboratory systems, reagents, accessories and consumables. It also markets self-monitoring medical devices for diagnosis and treatment of diabetes. The division operates throughout Israel to service the central laboratory, hospital, clinic, point of care and self-testing markets. Its activities in the medical and research fields in Israel cover all market segments: medical (private and public health services), research institutions and the biotech industry.
The Company competes with Dr. Reddy�� Laboratories, Ltd., Actavis Inc., Aaron Industries, Inc., Ohm Laboratories, Inc., PL Developments, LNK International, Inc., Abbott Laboratories, Mead Johnson Nutrition Co., Nestle S.A. (Gerber), Danone Baby Nutrition, Bayer AG, Pfizer, Inc., Rexall Sundown, Inc., Apotex, Glenmark Generics Inc., Impax, Prasco, Sandoz, Taro Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Triax Pharmaceuticals, and Zydus Pharmaceuticals.
Advisors' Opinion:- [By Benjamin Shepherd]
When you have a run-of-the-mill headache or cold, you take an aspirin or an antihistamine which you most likely picked up off a shelf at your pharmacy. You don�� see a doctor, you don�� have to talk to the pharmacist and you definitely don�� need a prescription for an over-the-counter (OTC) medication, some of which you might even take on a daily basis.
According to a paper from the American College of Preventative Medicine released in 2011, more than $17 billion of OTC products were sold in 2010 and more than a third of American adults reported using OTC medication on a regular basis. A survey conducted in 1999 showed that nearly 20 percent of the population used an OTC pain medication in any given week.
While there is the risk that readily available medications may be misused, OTC products are commonly used because they allow fast and direct access to effective medication for a whole host of common ailments. They also have the added benefit of helping to reduce the pressure on our health care system by preventing needless doctor calls.
When you think of OTC medications many of the first to come to mind, such as Tylenol, Sudafed and Benadryl, are products made by Johnson & Johnson (NYSE: JNJ). But over the past decade ��especially since the turmoil of the Great Recession ��there has been a rise in ��eneric generics,��otherwise known as store brands.
Most OTC medications have been around for decades, in the case of aspirin more than a century, and as a result have virtually no patent protections. That means that competition in the space has always been fierce and most manufacturers invest heavily in building up brand reputation for effectiveness, making it a relatively low margin business to begin with.
The market has become even more competitive since retailers have realized that they can keep more money in their own pockets by contracting for the production of virtually identical products which can be sold un - [By Laura Brodbeck]
Stocks moving in the pre-market included:
Wyndham Worldwide Corp (NYSE: WYN) gained 2.65 percent in pre-market trade, adding to its 4.02 percent rise over the past five days. Goldman Sachs Group Inc (NYSE: GS) gained 1.42 percent in pre-market trade after falling 0.95 percent on Wednesday. Perrigo Co (NYSE: PRGO) gained 0.66 percent in pre-market trade after losing 1.96 percent in the past week. U.S. Bancorp (NYSE: USB) lost 0.61 percent in pre-market trade after gaining 0.80 percent over the past five days.Earnings
No comments:
Post a Comment